Literature DB >> 3282073

Antigens recognised by the human immune response to infection with Leptospira interrogans serovar hardjo.

A J Chapman1, B Adler, S Faine.   

Abstract

Serum samples from patients infected with Leptospira interrogans serovar hardjo were tested by the microscopic agglutination test (MAT), enzyme immunoassay (EIA) and immunoblotting. There was no apparent correlation between MAT titre and EIA optical density (OD) for individual serum samples, but sequential serum samples produced similar profiles in both tests during the course of an infection. Immunoblotting of hardjo sonicate with patients' sera revealed reactions with a number of bands, in the mol. wt (10(3] range 14.4-95. However, all serum samples reacted with the major 28 x 10(3)-mol. wt sub-unit of hardjo lipopolysaccharide (LPS) and most reacted with a (34.5-35) x 10(3)-mol. wt flagella doublet. Examination of sequential serum samples obtained over a period of about 3 months after infection revealed little change in the antigens detected after the second to third week of infection. Absorption of patients' sera with whole viable leptospires revealed that antibodies to several exposed antigens, including LPS, were produced. Sera which reacted with hardjo flagella also reacted with bands of similar mol. wts in preparations from other serovars.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3282073     DOI: 10.1099/00222615-25-4-269

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  16 in total

Review 1.  Leptospirosis.

Authors:  P N Levett
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

2.  Leptospiral proteins recognized during the humoral immune response to leptospirosis in humans.

Authors:  H Guerreiro; J Croda; B Flannery; M Mazel; J Matsunaga; M Galvão Reis; P N Levett; A I Ko; D A Haake
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

3.  Leptospira immunoglobulin-like proteins as a serodiagnostic marker for acute leptospirosis.

Authors:  Julio Croda; João G R Ramos; James Matsunaga; Adriano Queiroz; Akira Homma; Lee W Riley; David A Haake; Mitermayer G Reis; Albert I Ko
Journal:  J Clin Microbiol       Date:  2007-03-14       Impact factor: 5.948

4.  Development of an enzyme-linked immunosorbent assay using a recombinant LigA fragment comprising repeat domains 4 to 7.5 as an antigen for diagnosis of equine leptospirosis.

Authors:  Weiwei Yan; Muhammad Hassan Saleem; Patrick McDonough; Sean P McDonough; Thomas J Divers; Yung-Fu Chang
Journal:  Clin Vaccine Immunol       Date:  2013-05-29

5.  FlaA, a putative flagellar outer sheath protein, is not an immunodominant antigen associated with Lyme disease.

Authors:  Y Ge; N W Charon
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

6.  Use of recombinant flagellin protein as a tracer antigen in a fluorescence polarization assay for diagnosis of leptospirosis.

Authors:  N I Bughio; M Lin; O P Surujballi
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

7.  Characterization of an antigenic oligosaccharide from Leptospira interrogans serovar pomona and its role in immunity.

Authors:  A Midwinter; T Vinh; S Faine; B Adler
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

8.  Evaluation of recombinant Leptospira antigen-based enzyme-linked immunosorbent assays for the serodiagnosis of leptospirosis.

Authors:  B Flannery; D Costa; F P Carvalho; H Guerreiro; J Matsunaga; E D Da Silva; A G Ferreira; L W Riley; M G Reis; D A Haake; A I Ko
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

9.  Detection and characterization of leptospiral antigens using a biotin/avidin double-antibody sandwich enzyme-linked immunosorbent assay and immunoblot.

Authors:  M J Champagne; R Higgins; J M Fairbrother; D Dubreuil
Journal:  Can J Vet Res       Date:  1991-07       Impact factor: 1.310

10.  Effect of heat or formalin treatment of leptospires on antibody response detected by immunoblotting.

Authors:  V Pope; R C Johnson
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.